Gilliland FD,Hunt WC,Morris DM,Key CR. (1997). Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer, 79(3), 564-573. https://doi.org/10.1002/(sici)1097-0142(19970201)79:3<564::aid-cncr20>3.0.co;2-0

Article  PubMed  CAS  Google Scholar 

Abe I,Lam AK. (2021). Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging. Histol Histopathol, 36(3), 239-248. https://doi.org/10.14670/HH-18-277

Article  PubMed  Google Scholar 

Ragazzi M,Ciarrocchi A,Sancisi V,Gandolfi G,Bisagni A,Piana S. (2014). Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol, 2014, 790834. https://doi.org/10.1155/2014/790834

Article  PubMed  PubMed Central  CAS  Google Scholar 

WHO Classification of Tumours Editorial Board. Endocrine and neuroendocrine tumours: Lyon, France; International Agency for Research on Cancer: 2022, 10, https://tumourclassification.iarc.who.int.

Bible KC,Kebebew E,Brierley J,Brito JP,Cabanillas ME,Clark TJ, Jr.,Di Cristofano A,Foote R,Giordano T,Kasperbauer J, et al. (2021). 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid, 31(3), 337-386. https://doi.org/10.1089/thy.2020.0944

Article  PubMed  PubMed Central  Google Scholar 

Filetti S,Durante C,Hartl D,Leboulleux S,Locati LD,Newbold K,Papotti MG,Berruti A,clinicalguidelines@esmo.org EGCEa. (2019). Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol, 30(12), 1856-1883. https://doi.org/10.1093/annonc/mdz400

Article  PubMed  CAS  Google Scholar 

Xu B,Fuchs T,Dogan S,Landa I,Katabi N,Fagin JA,Tuttle RM,Sherman E,Gill AJ,Ghossein R. (2020). Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases. Thyroid, 30(10), 1505-1517. https://doi.org/10.1089/thy.2020.0086

Article  PubMed  PubMed Central  CAS  Google Scholar 

Landa I,Ibrahimpasic T,Boucai L,Sinha R,Knauf JA,Shah RH,Dogan S,Ricarte-Filho JC,Krishnamoorthy GP,Xu B, et al. (2016). Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest, 126(3), 1052-1066. https://doi.org/10.1172/JCI85271

Article  PubMed  PubMed Central  Google Scholar 

Jannin A,Escande A,Al Ghuzlan A,Blanchard P,Hartl D,Chevalier B,Deschamps F,Lamartina L,Lacroix L,Dupuy C, et al. (2022). Anaplastic Thyroid Carcinoma: An Update. Cancers (Basel), 14(4), 1061. https://doi.org/10.3390/cancers14041061

Article  PubMed  CAS  Google Scholar 

Sheehan-Rooney K,Palinkasova B,Eberhart JK,Dixon MJ. (2010). A cross-species analysis of Satb2 expression suggests deep conservation across vertebrate lineages. Dev Dyn, 239(12), 3481-3491. https://doi.org/10.1002/dvdy.22483

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hassan MQ,Gordon JA,Beloti MM,Croce CM,van Wijnen AJ,Stein JL,Stein GS,Lian JB. (2010). A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A, 107(46), 19879-19884. https://doi.org/10.1073/pnas.1007698107

Article  PubMed  PubMed Central  Google Scholar 

Dobreva G,Chahrour M,Dautzenberg M,Chirivella L,Kanzler B,Farinas I,Karsenty G,Grosschedl R. (2006). SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell, 125(5), 971-986. https://doi.org/10.1016/j.cell.2006.05.012

Article  PubMed  CAS  Google Scholar 

Magnusson K,de Wit M,Brennan DJ,Johnson LB,McGee SF,Lundberg E,Naicker K,Klinger R,Kampf C,Asplund A, et al. (2011). SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol, 35(7), 937-948. https://doi.org/10.1097/PAS.0b013e31821c3dae

Article  PubMed  Google Scholar 

Dragomir A,de Wit M,Johansson C,Uhlen M,Ponten F. (2014). The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study. Am J Clin Pathol, 141(5), 630-638. https://doi.org/10.1309/AJCPWW2URZ9JKQJU

Article  PubMed  Google Scholar 

Davis JL,Horvai AE. (2016). Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas. Histopathology, 69(1), 84-90. https://doi.org/10.1111/his.12911

Article  PubMed  Google Scholar 

Conner JR,Hornick JL. (2013). SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology, 63(1), 36-49. https://doi.org/10.1111/his.12138

Article  PubMed  Google Scholar 

De Michele S,Remotti HE,Del Portillo A,Lagana SM,Szabolcs M,Saqi A. (2021). SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins. Am J Clin Pathol, 155(1), 124-132. https://doi.org/10.1093/ajcp/aqaa118

Article  PubMed  CAS  Google Scholar 

Ma C,Olevian D,Miller C,Herbst C,Jayachandran P,Kozak MM,Chang DT,Pai RK. (2019). SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Mod Pathol, 32(8), 1217-1231. https://doi.org/10.1038/s41379-019-0265-1

Article  PubMed  CAS  Google Scholar 

Warmke LM,Maloney N,Leung CH,Lin H,Lazar AJ,Wang WL. (2022). SATB2 Expression in Undifferentiated Pleomorphic Sarcomas of Bone. Am J Clin Pathol, 158(2), 235-241. https://doi.org/10.1093/ajcp/aqac033

Article  PubMed  CAS  Google Scholar 

Machado I,Navarro S,Picci P,Llombart-Bosch A. (2016). The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Pathol Res Pract, 212(9), 811-816. https://doi.org/10.1016/j.prp.2016.06.012

Article  PubMed  CAS  Google Scholar 

Creytens D. (2020). SATB2 and TLE1 Expression in BCOR-CCNB3 (Ewing-like) Sarcoma, Mimicking Small Cell Osteosarcoma and Poorly Differentiated Synovial Sarcoma. Appl Immunohistochem Mol Morphol, 28(1), e10-e12. https://doi.org/10.1097/PAI.0000000000000601

Article  PubMed  CAS  Google Scholar 

Berg KB,Churg A. (2017). GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung. Am J Surg Pathol, 41(9), 1221-1225. https://doi.org/10.1097/PAS.0000000000000825

Article  PubMed  Google Scholar 

Ponten F,Jirstrom K,Uhlen M. (2008). The Human Protein Atlas--a tool for pathology. J Pathol, 216(4), 387-393. https://doi.org/10.1002/path.2440

Article  PubMed  CAS  Google Scholar 

Haase J,Misiak D,Bauer M,Pazaitis N,Braun J,Potschke R,Mensch A,Bell JL,Dralle H,Siebolts U, et al. (2021). IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol, 34(1), 32-41. https://doi.org/10.1038/s41379-020-0630-0

Article  PubMed  CAS  Google Scholar 

Koster J,Volckmann R,Zwijnenburg D,Molenaar P,Versteeg R. (2019). Abstract 2490: R2: Genomics analysis and visualization platform. Cancer Research, 79(13_Supplement), 2490–2490. https://doi.org/10.1158/1538-7445.Am2019-2490

Luo H,Xia X,Kim GD,Liu Y,Xue Z,Zhang L,Shu Y,Yang T,Chen Y,Zhang S, et al. (2021). Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci Adv, 7(31). https://doi.org/10.1126/sciadv.abf3657

Mao R,Shi L,Yan W,Li W,Li B,Li X. (2020). Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eosinophilia: A case report. Medicine (Baltimore), 99(42), e22783. https://doi.org/10.1097/MD.0000000000022783

Article  PubMed  Google Scholar 

Nguyen D,Htun NN,Wang B,Lee B,Johnson C. (2023). An Anaplastic Thyroid Carcinoma of the Giant-Cell Type from a Mediastinal Ectopic Thyroid Gland. Diagnostics (Basel), 13(18), 2941. https://doi.org/10.3390/diagnostics13182941

Article  PubMed  Google Scholar 

Kamashki A,Rivera M,Sturgis C. (2023). Fine Needle Aspiration and Core Biopsy of Liver Mass as First Time Diagnosis of Sarcomatoid Anaplastic Thyroid Carcinoma, A Rare Malignancy Presenting at an Unexpected Body Site. American Journal of Clinical Pathology, 160(Supplement_1), S58-S58. https://doi.org/10.1093/ajcp/aqad150.130

Dum D,Kromm D,Lennartz M,De Wispelaere N,Buscheck F,Luebke AM,Burandt E,Menz A,Kluth M,Hube-Magg C, et al. (2023). SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors. Arch Pathol Lab Med, 147(4), 451-464. https://doi.org/10.5858/arpa.2021-0317-OA

Article  PubMed  CAS  Google Scholar